Evidence map›Paper›PMID 37872141›Full record

ReviewNature communications2023

A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.

Sandra Van Puyvelde, Tessa de Block, Sushmita Sridhar, Matt Bawn, Robert A Kingsley, Brecht Ingelbeen, Mathew A Beale, Barbara Barbé, Hyon Jin Jeon, Lisette Mbuyi-Kalonji and 38 more

Open access · goldAbstract readReview
In one paragraph

Review in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Outbreak of multidrug-resistant Salmonella typhimurium monophasic variant 1,4,[5],12:i:- sequence type 34 linked to food, in China.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  4. Microbial genomics · 2026
    Article
  5. Article
  6. Host adaptation inApplied and environmental microbiology · 2026
    Review
  7. Article
  8. Article
  9. Multivalent vaccines for invasiveInfection and immunity · 2026
    Review
  10. Article
  11. Infection strategies ofGut microbes reports · 2026
    Review
  12. Virulence and antimicrobial resistance inFrontiers in microbiology · 2026
    Review
  13. Genomic epidemiology ofFrontiers in microbiology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors at 20 institutions in 21 countries.

Sandra Van PuyveldeCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK. sandra.vanpuyvelde@uantwerpen.be.ORCID 0000-0001-8434-5732
Tessa de BlockInstitute of Tropical Medicine, Antwerp, Belgium.
Sushmita SridharCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.ORCID 0000-0001-7453-7482
Matt BawnQuadram Institute Bioscience, Norwich, UK.ORCID 0000-0001-7245-4034
Robert A KingsleyQuadram Institute Bioscience, Norwich, UK.ORCID 0000-0002-0194-6485
Brecht IngelbeenInstitute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-2214-6858
Mathew A BealeParasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-4740-3187
Barbara BarbéInstitute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0003-4978-3379
Hyon Jin JeonCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
Lisette Mbuyi-KalonjiDepartment of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID 0000-0002-5092-8689
Marie-France PhobaDepartment of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Dadi FalayDepartment of Pediatrics, University Hospital of Kisangani, Kisangani, Democratic Republic of the Congo.
Delphine MartinyDepartment of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), 1000, Brussels, Belgium.
Olivier VandenbergDepartment of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), 1000, Brussels, Belgium.ORCID 0000-0003-0484-4502
Dissou AffolabiCentre National Hospitalier Universitaire Hubert Koutoukou Maga, Cotonou, Benin.
Jean Pierre RutangaInstitute of Tropical Medicine, Antwerp, Belgium.
Pieter-Jan CeyssensNational Reference Center for Salmonella, Unit of Human Bacterial Diseases, Sciensano, J. Wytsmanstraat 14, B-1050, Brussels, Belgium.
Wesley MattheusNational Reference Center for Salmonella, Unit of Human Bacterial Diseases, Sciensano, J. Wytsmanstraat 14, B-1050, Brussels, Belgium.
Wim L CuypersInstitute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-1895-3526
Marianne A B van der SandeInstitute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-4778-6739
Se Eun ParkInternational Vaccine Institute, 1 Gwanak-ro, Seoul, 08826, Republic of Korea.ORCID 0000-0002-1632-3045
Simon KariukiKenya Medical Research Institute/Centre for Global Health Research, Kisumu, Kenya.
Kephas OtienoKenya Medical Research Institute/Centre for Global Health Research, Kisumu, Kenya.
John P A LusinguNational Institute for Medical Research, Tanga, Tanzania.
Joyce R MbwanaNational Institute for Medical Research, Tanga, Tanzania.ORCID 0000-0001-5471-6555
Samuel AdjeiUniversity of Health & Allied Sciences, Ho, Volta Region, Ghana.
Anima SarfoUniversity of Health & Allied Sciences, Ho, Volta Region, Ghana.
Seth O AgyeiUniversity of Health & Allied Sciences, Ho, Volta Region, Ghana.
Kwaku P AsanteKintampo Health Research Centre, Research and Development Division, Ghana Health Service, Kintampo North Municipality, Ho, Volta Region, Ghana.
Walter OtienoKEMRI/Walter Reed Project, Kombewa, Kenya.
Lucas OtienoKEMRI/Walter Reed Project, Kombewa, Kenya.
Marc C TahitaInstitut de Recherche en Science de la Santé, Direction Régionale du Centre-Ouest/ClinicalResearch Unit of Nanoro, Nanoro, Burkina Faso.ORCID 0000-0003-2158-0182
Palpouguini LompoInstitut de Recherche en Science de la Santé, Direction Régionale du Centre-Ouest/ClinicalResearch Unit of Nanoro, Nanoro, Burkina Faso.
Irving F HoffmanUniversity of North Carolina Project, Lilongwe, Malawi.
Tisungane MvaloUniversity of North Carolina Project, Lilongwe, Malawi.ORCID 0000-0002-6775-7919
Chisomo MsefulaMalawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
Fatimah Hassan-HangaDepartment of Paediatrics, Bayero University, Kano, Nigeria.
Stephen ObaroUniversity of Nebraska Medical Center, Omaha, NE, USA.
Grant MackenzieMedical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Stijn DeborggraeveInstitute of Tropical Medicine, Antwerp, Belgium.
Nicholas FeaseyUniversity of North Carolina Project, Lilongwe, Malawi.ORCID 0000-0003-4041-1405
Florian MarksCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.ORCID 0000-0002-6043-7170
Calman A MacLennanThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-9694-0846
Nicholas R ThomsonParasites and Microbes Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-4432-8505
Jan JacobsInstitute of Tropical Medicine, Antwerp, Belgium.ORCID 0000-0002-8657-6777
Gordon Dougan *Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
Samuel Kariuki *Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.ORCID 0000-0003-3209-9503
Octavie Lunguya *Department of Medical Biology, University Teaching Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Instituut voor Tropische Geneeskunde · BEInternational Vaccine Institute · KRKenya Medical Research Institute · KENational Institute of Biomedical Research · CDUniversity of Health and Allied Sciences · GHInstitut de Recherche en Sciences de la Santé · BFSciensano (Belgium) · BEUniversity of Antwerp · BEUtrecht University · NLWellcome Sanger Institute · GBAminu Kano Teaching Hospital · NGCentre National Hospitalier et Universitaire Hubert Koutoukou MAGA · BJGates Foundation · USHarvard University · USKintampo Health Research Centre · GHLiverpool School of Tropical Medicine · GBLondon School of Hygiene & Tropical Medicine · GBNational Institute for Medical Research · TZUniversité de Kisangani · CDUniversité Libre de Bruxelles · BE

Funding

Wellcome Trust
6 · The paper itself

Abstract

Invasive non-typhoidal Salmonella (iNTS) disease manifesting as bloodstream infection with high mortality is responsible for a huge public health burden in sub-Saharan Africa. Salmonella enterica serovar Typhimurium (S. Typhimurium) is the main cause of iNTS disease in Africa. By analysing whole genome sequence data from 1303 S. Typhimurium isolates originating from 19 African countries and isolated between 1979 and 2017, here we show a thorough scaled appraisal of the population structure of iNTS disease caused by S. Typhimurium across many of Africa's most impacted countries. At least six invasive S. Typhimurium clades have already emerged, with ST313 lineage 2 or ST313-L2 driving the current pandemic. ST313-L2 likely emerged in the Democratic Republic of Congo around 1980 and further spread in the mid 1990s. We observed plasmid-borne as well as chromosomally encoded fluoroquinolone resistance underlying emergences of extensive-drug and pan-drug resistance. Our work provides an overview of the evolution of invasive S. Typhimurium disease, and can be exploited to target control measures.

Indexed as

Salmonella InfectionsSalmonella typhimuriumAfrica South of the SaharaDrug Resistance, MicrobialGenomicsHumans

Identifiers

PMID37872141
PMCPMC10593746
OpenAlexW4387878842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.